Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk.


Journal

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: United States
ID NLM: 8610640

Informations de publication

Date de publication:
03 2022
Historique:
revised: 30 11 2021
received: 01 10 2021
accepted: 14 12 2021
pubmed: 26 12 2021
medline: 16 4 2022
entrez: 25 12 2021
Statut: ppublish

Résumé

Prevalence of osteoporosis is more than 50% in older adults, yet current clinical methods for diagnosis that rely on areal bone mineral density (aBMD) fail to detect most individuals who have a fragility fracture. Bone fragility can manifest in different forms, and a "one-size-fits-all" approach to diagnosis and management of osteoporosis may not be suitable. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides additive information by capturing information about volumetric density and microarchitecture, but interpretation is challenging because of the complex interactions between the numerous properties measured. In this study, we propose that there are common combinations of bone properties, referred to as phenotypes, that are predisposed to different levels of fracture risk. Using HR-pQCT data from a multinational cohort (n = 5873, 71% female) between 40 and 96 years of age, we employed fuzzy c-means clustering, an unsupervised machine-learning method, to identify phenotypes of bone microarchitecture. Three clusters were identified, and using partial correlation analysis of HR-pQCT parameters, we characterized the clusters as low density, low volume, and healthy bone phenotypes. Most males were associated with the healthy bone phenotype, whereas females were more often associated with the low volume or low density bone phenotypes. Each phenotype had a significantly different cumulative hazard of major osteoporotic fracture (MOF) and of any incident osteoporotic fracture (p < 0.05). After adjustment for covariates (cohort, sex, and age), the low density followed by the low volume phenotype had the highest association with MOF (hazard ratio = 2.96 and 2.35, respectively), and significant associations were maintained when additionally adjusted for femoral neck aBMD (hazard ratio = 1.69 and 1.90, respectively). Further, within each phenotype, different imaging biomarkers of fracture were identified. These findings suggest that osteoporotic fracture risk is associated with bone phenotypes that capture key features of bone deterioration that are not distinguishable by aBMD. © 2021 American Society for Bone and Mineral Research (ASBMR).

Identifiants

pubmed: 34953074
doi: 10.1002/jbmr.4494
pmc: PMC9249128
mid: NIHMS1817047
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

428-439

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201500001C
Pays : United States
Organisme : CIHR
ID : 364554
Pays : Canada
Organisme : NIAMS NIH HHS
ID : R01 AR061445
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NIAMS NIH HHS
ID : AR027065
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC25195
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01AR061445
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR027065
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01-HC-25195
Pays : United States

Informations de copyright

© 2021 American Society for Bone and Mineral Research (ASBMR).

Références

Am J Med. 1983 Dec;75(6):899-901
pubmed: 6650542
J Bone Miner Res. 2016 Aug;31(8):1485-7
pubmed: 27335158
Osteoporos Int. 2005 Mar;16 Suppl 2:S3-7
pubmed: 15365697
J Bone Miner Res. 2011 Jan;26(1):50-62
pubmed: 20593413
Calcif Tissue Int. 2018 Jan;102(1):14-22
pubmed: 28913616
JAMA. 2001 Feb 14;285(6):785-95
pubmed: 11176917
Bone. 2002 Jun;30(6):842-8
pubmed: 12052451
J Clin Endocrinol Metab. 2005 Dec;90(12):6508-15
pubmed: 16189253
J Bone Miner Res. 2018 Jan;33(1):54-62
pubmed: 28929525
J Bone Miner Res. 2006 Apr;21(4):529-35
pubmed: 16598372
J Bone Miner Res. 2017 Jun;32(6):1218-1228
pubmed: 28084657
Osteoporos Int. 2012 Nov;23(11):2591-600
pubmed: 22398854
J Bone Miner Res. 2018 Jun;33(6):987-1000
pubmed: 29394462
J Bone Miner Res. 2018 Oct;33(10):1889-1899
pubmed: 29893993
Lancet Diabetes Endocrinol. 2019 Jan;7(1):34-43
pubmed: 30503163
Osteoporos Int. 2015 Oct;26(10):2431-40
pubmed: 25956285
Calcif Tissue Int. 2019 Sep;105(3):252-262
pubmed: 31187198
Osteoporos Int. 2013 May;24(5):1733-40
pubmed: 23179565
J Bone Miner Res. 2018 Feb;33(2):328-337
pubmed: 28960489
J Bone Miner Res. 2019 May;34(5):825-837
pubmed: 30715752
J Bone Miner Res. 2013 Oct;28(10):2177-85
pubmed: 23572415
J Struct Biol. 2020 Dec 1;212(3):107650
pubmed: 33096230
Bone. 2008 Jun;42(6):1203-13
pubmed: 18358799
Osteoporos Int. 2010 Jul;21(7):1227-36
pubmed: 19859644
Osteoporos Int. 2016 Oct;27(10):3023-32
pubmed: 27166680
J Osteoporos. 2012;2012:129760
pubmed: 22496983
J Bone Miner Res. 2017 Jul;32(7):1505-1513
pubmed: 28294405
J Bone Miner Res. 1998 May;13(5):763-73
pubmed: 9610739
Osteoporos Int. 2020 Sep;31(9):1607-1627
pubmed: 32458029
J Biomech. 2018 Oct 26;80:63-71
pubmed: 30201250
J Bone Miner Res. 2007 Mar;22(3):465-75
pubmed: 17144789
J Bone Miner Res. 2017 Jun;32(6):1243-1251
pubmed: 28276092
J Bone Miner Res. 2016 Nov;31(11):2041-2047
pubmed: 27192388
Orphanet J Rare Dis. 2020 Sep 16;15(1):251
pubmed: 32938479
Lancet. 2002 May 25;359(9320):1841-50
pubmed: 12044392
J Bone Miner Res. 2010 Nov;25(11):2313-23
pubmed: 20499368
Bone. 2007 Oct;41(4):505-15
pubmed: 17693147
Am J Med. 1997 Aug 18;103(2A):3S-8S; discussion 8S-11S
pubmed: 9302892
Clin Orthop Relat Res. 2015 Aug;473(8):2530-9
pubmed: 25690167
Bone. 1997 Mar;20(3):213-8
pubmed: 9071471
N Engl J Med. 2006 May 25;354(21):2250-61
pubmed: 16723616
Bone. 2012 Jun;50(6):1304-10
pubmed: 22445540
Arch Osteoporos. 2017 Dec 27;13(1):2
pubmed: 29282548
Nat Rev Endocrinol. 2019 Sep;15(9):535-547
pubmed: 31189982
Bone. 2016 Jul;88:131-137
pubmed: 27130873

Auteurs

Danielle E Whittier (DE)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Elizabeth J Samelson (EJ)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew Senior Life, Boston, MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Marian T Hannan (MT)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew Senior Life, Boston, MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Lauren A Burt (LA)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, Canada.

David A Hanley (DA)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Emmanuel Biver (E)

Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Pawel Szulc (P)

INSERM UMR1033, Université de Lyon, Hôpital Edouard Herriot, Lyon, France.

Elisabeth Sornay-Rendu (E)

INSERM UMR1033, Université de Lyon, Hôpital Edouard Herriot, Lyon, France.

Blandine Merle (B)

INSERM UMR1033, Université de Lyon, Hôpital Edouard Herriot, Lyon, France.

Roland Chapurlat (R)

INSERM UMR1033, Université de Lyon, Hôpital Edouard Herriot, Lyon, France.

Eric Lespessailles (E)

Regional Hospital of Orleans, PRIMMO, Orleans, France.
EA 4708-I3MTO, University of Orleans, Orleans, France.

Andy Kin On Wong (AKO)

Joint Department of Medical Imaging, University Health Network, Toronto, Canada.
Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

David Goltzman (D)

Department of Medicine, McGill University and McGill University Health Centre, Quebec, Canada.

Sundeep Khosla (S)

Kogod Center on Aging and Division of Endocrinology, Mayo Clinic, Rochester, MN, USA.

Serge Ferrari (S)

Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Mary L Bouxsein (ML)

Center for Advanced Orthopedic Studies, BIDMC, Boston, MA, USA.
Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
Department of Orthopedic Surgery, Harvard Medical School, Boston, MA, USA.

Douglas P Kiel (DP)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew Senior Life, Boston, MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Steven K Boyd (SK)

McCaig Institute for Bone and Joint Health, Cumming School of Medicine, University of Calgary, Calgary, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH